NCT04553133 2026-04-13PF-07104091 as a Single Agent and in Combination TherapyPfizerPhase 2 Active not recruiting157 enrolled
NCT06257264 2026-03-05A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage TumorsBeOne MedicinesPhase 1 Recruiting258 enrolled